Flowflex SARS-CoV-2 Antigen Rapid Test

The Flowflex SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens directly from individuals who are suspected of an active COVID-19 infection by their healthcare provider within the first seven days of the onset of symptoms. • Nasal swab specimens • Results in 15 minutes • Excellent performance compared to molecular methods • Room temperature storage

Clinical Performance 

The performance of Flowflex SARS-CoV-2 Antigen Rapid Test was established with 304 nasal swabs collected from individual symptomatic patients (within 7 days of onset) who were suspected of COVID-19. The performance of the Flowflex SARS-CoV-2 Antigen Rapid Test was compared to a RTPCR method.

Materials Provided

Test Cassettes • Quick Reference Instructions • Extraction Buffer • Nasal Swabs • Extraction Buffer Tubes • Negative Control Swab • Positive Control Swab • Package Insert

Test Procedure and Interpretation